Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 27

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 27
---
-1 |
| Annex B — Plan of Merger                                                                           |     |  B-1 |
| Annex C — Amendments to Existing Governing Documents                                               |     |  C-1 |
| Annex D — Company M&A                                                                              |     |  D-1 |

i About This Proxy Statement / Prospectus This document, which forms part of a registration statement on Form F -4filed with the SEC by OmnigenicsAI, constitutes a prospectus of OmnigenicsAI under Section 5 of the Securities Act, with respect to the Company Shares to be issued to the SPAC Shareholders and Company Warrants to be issued to the holders of Public Warrants if the Business Combination described herein is consummated. With respect to APx and the holders of SPAC Ordinary Shares, this proxy statement/prospectus serves as and constitutes: •a notice of meeting and a proxy statement under Section 14(a) of Exchange Act with respect to the Special Meeting of APx shareholders being held on , 2025, where APx shareholders will vote on, among other things, the proposed Business Combination and related transactions and each of the below proposals; and •a prospectus of OmnigenicsAI under Section 5 of the Securities Act, with respect to the Company Shares and Company Warrants to be issued to the holders of SPAC Ordinary Shares and Public Warrants and the Company Shareholders if the Business Combination described herein is consummated. This document does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction or to any person to whom it would be unlawful to make such offer. ROUNDING OF FIGURES Certain financial information presented in tables in this prospectus has been rounded to the nearest whole number or the nearest decimal place. Therefore, the sum of the numbers in a column may not conform exactly to the total figure given for that column. In addition, certain percentages presented in the tables in this proxy statement/prospectus reflect calculations based upon the underlying information prior to rounding, and, accordingly, may not conform exactly to the percentages that would be derived if the relevant calculations were based upon the rounded numbers. Certain percentage shareholdings have also been rounded and therefore totals of such percentage shareholdings may vary slightly from their actual arithmetic totals. Market and Industry Data Where information has been sourced from a third party, the source of such information has been identified. Unless otherwise indicated, the information contained in this proxy statement/prospectus on the market environment, market developments, growth rates, market